Computational strategy for intrinsically disordered protein ligand design leads to the discovery of p53 transactivation domain I binding compounds that activate the p53 pathway
Open Access
- 28 December 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 12 (8) , 3004-3016
Abstract
A hierarchical computational strategy for IDP drug virtual screening (IDPDVS) was proposed and successfully applied to identify compounds that bind p53 TAD1 and restore wild-type p53 function in cancer cells.Keywords
Funding Information
- National Natural Science Foundation of China (21633001)
- National Natural Science Foundation of China (21877003)
- Ministry of Science and Technology of the People's Republic of China (2016YFA0502303)
This publication has 77 references indexed in Scilit:
- Discovery of selective bioactive small molecules by targeting an RNA dynamic ensembleNature Chemical Biology, 2011
- Constructing ensembles for intrinsically disordered proteinsCurrent Opinion in Structural Biology, 2011
- Intrinsically disordered proteins are potential drug targetsCurrent Opinion in Chemical Biology, 2010
- A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcomaNature Medicine, 2009
- Structural Basis for p300 Taz2-p53 TAD1 Binding and Modulation by PhosphorylationStructure, 2009
- Intrinsically Disordered Proteins in Human Diseases: Introducing the D2ConceptAnnual Review of Biophysics, 2008
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibitionProceedings of the National Academy of Sciences, 2008
- Binding Induced Folding in p53−MDM2 ComplexJournal of the American Chemical Society, 2007
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumorsNature Medicine, 2004